Literature DB >> 29570162

IL-34 Inhibits Acute Rejection of Rat Liver Transplantation by Inducing Kupffer Cell M2 Polarization.

Zhengfei Zhao1, Guangrui Pan1, Chengyong Tang2, Zhongtang Li1, Daofeng Zheng1, Xufu Wei1, Zhongjun Wu1.   

Abstract

BACKGROUND: Recent studies have demonstrated that IL-34 is implicated in the regulation of macrophage functions. However, the effect of IL-34 on Kupffer cells (KCs) in acute rejection (AR) of liver transplantation remains unclear.
METHODS: IL-34 expression was detected in graft and serum from allotransplantation and syngeneic transplantation groups. The adeno-associated virus-expressing IL-34 was used to assess the effect of IL-34 on AR of rat liver transplantation. The effect of IL-34 on KC polarization was evaluated by in vitro and in vivo assays. Kupffer cells in donors were depleted by clodronate treatment before transplantation, and the nontreated KCs or lipopolysaccharide-treated KCs were transferred into recipients during liver transplantation.
RESULTS: IL-34 expression levels in grafts and serum were decreased in the allotransplantation group compared with the syngeneic transplantation group. Adeno-associated virus-expressing IL-34 treatment induced KC M2 polarization in vivo and inhibited the AR of rat liver transplantation. Moreover, we found that IL-34 switched the phenotype of KCs from M1 to M2 by activating the PI3K/Akt pathway in vitro. In addition, the results of KC deletion and adaptive transfer experiments showed that the AR inhibition induced by IL-34 was M2 KC-dependent.
CONCLUSIONS: IL-34 plays an important role in KC M2 polarization-dependent AR inhibition of rat liver transplantation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29570162     DOI: 10.1097/TP.0000000000002194

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  12 in total

Review 1.  Interleukin 30 to Interleukin 40.

Authors:  Jovani Catalan-Dibene; Laura L McIntyre; Albert Zlotnik
Journal:  J Interferon Cytokine Res       Date:  2018-10       Impact factor: 2.607

Review 2.  Interleukin-34 Mediates Cross-Talk Between Stromal Cells and Immune Cells in the Gut.

Authors:  Giovanni Monteleone; Eleonora Franzè; Edoardo Troncone; Claudia Maresca; Irene Marafini
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

3.  Landscape of Immune Cells Heterogeneity in Liver Transplantation by Single-Cell RNA Sequencing Analysis.

Authors:  Xinqiang Li; Shipeng Li; Bin Wu; Qingguo Xu; Dahong Teng; Tongwang Yang; Yandong Sun; Yang Zhao; Tianxiang Li; Dan Liu; Shuang Yang; Weihua Gong; Jinzhen Cai
Journal:  Front Immunol       Date:  2022-05-10       Impact factor: 8.786

Review 4.  Macrophage Modification Strategies for Efficient Cell Therapy.

Authors:  Anastasiya S Poltavets; Polina A Vishnyakova; Andrey V Elchaninov; Gennady T Sukhikh; Timur Kh Fatkhudinov
Journal:  Cells       Date:  2020-06-24       Impact factor: 6.600

5.  Macrophage Membrane-Coated Nanoparticles Alleviate Hepatic Ischemia-Reperfusion Injury Caused by Orthotopic Liver Transplantation by Neutralizing Endotoxin.

Authors:  Zhibing Ou; Hua Zhong; Liang Zhang; Minghua Deng; Wenfeng Zhang; Jingyuan Wang; Huaguo Feng; Jianping Gong; Chunmu Miao; Zhujun Yi
Journal:  Int J Nanomedicine       Date:  2020-06-11

6.  IL-4 Alleviates Ischaemia-Reperfusion Injury by Inducing Kupffer Cells M2 Polarization via STAT6-JMJD3 Pathway after Rat Liver Transplantation.

Authors:  Minghua Deng; Jingyuan Wang; Hao Wu; Menghao Wang; Ding Cao; Jinzheng Li; Yakun Wu; Jianping Gong
Journal:  Biomed Res Int       Date:  2020-03-18       Impact factor: 3.411

7.  Low-dose IL-34 has no effect on osteoclastogenesis but promotes osteogenesis of hBMSCs partly via activation of the PI3K/AKT and ERK signaling pathways.

Authors:  Jianxiang Xu; Lifeng Fu; Jinwu Bai; Huiming Zhong; Zhihui Kuang; Chengwei Zhou; Bin Hu; Licheng Ni; Li Ying; Erman Chen; Wei Zhang; Jiaqi Wu; Deting Xue; Weixu Li; Zhijun Pan
Journal:  Stem Cell Res Ther       Date:  2021-05-04       Impact factor: 6.832

8.  Inhibition of miR-450b-5p ameliorates hepatic ischemia/reperfusion injury via targeting CRYAB.

Authors:  Zuotian Huang; Tong Mou; Yunhai Luo; Xingyu Pu; Junliang Pu; Lei Wan; Junhua Gong; Hang Yang; Yanyao Liu; Zhongtang Li; Ai Shen; Zhongjun Wu
Journal:  Cell Death Dis       Date:  2020-06-12       Impact factor: 8.469

Review 9.  Immunomodulation of Interleukin-34 and its Potential Significance as a Disease Biomarker and Therapeutic Target.

Authors:  Yun Ge; Man Huang; Yong-Ming Yao
Journal:  Int J Biol Sci       Date:  2019-07-20       Impact factor: 6.580

Review 10.  The M-CSF receptor in osteoclasts and beyond.

Authors:  Se Hwan Mun; Peter Sang Uk Park; Kyung-Hyun Park-Min
Journal:  Exp Mol Med       Date:  2020-08-17       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.